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used to assess cartilage damage. FGF9 treatment reduced the cartilage
degeneration score for the outer region of the medial tibial plateau by
33% (p ¼ 0.004), the width of signiﬁcant cartilage damage by 38% (p ¼
0.018), and the depth of cartilage lesions by 20-44% (p ¼ 0.003). Image
analysis showed that FGF9 increased the total cartilage area by 24% (p<
0.001) and the viable cartilage area by 35% (p < 0.001). Proteoglycan
loss was reduced by 43% (p ¼ 0.003) and the area that showed minimal
damage to the collagenwas increased two-fold. FGF9 had no signiﬁcant
effect on the subchondral bone but increased the size of the chon-
drophytes/osteophytes by 29% (p ¼ 0.001).
Conclusions: The local delivery of FGF9 in an OA model provided
signiﬁcant beneﬁcial effect on the damaged cartilage. Our data indicates
that FGF9 may be a disease-modifying drug candidate for the treatment
of osteoarthritis.
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INCREASED METHYLATION STATUS OF SOX9 GENE PROMOTER IN
HUMAN OSTEOARTHRITIC CARTILAGE
K. Kim, J. Lee, J. Lee, G.-I. Im. Dongguk Univ. Ilsan Hosp., Goyang, Republic
of Korea
Purpose: DNA methylation and modiﬁcation of nucleosome histone
tails are essential contributors to the mechanisms of epigenetic control
of gene expression. In this study, we tested the hypothesis that meth-
ylation status of SOX-9 gene promoter region is different in osteoar-
thritic (OA) cartilage from those of normal cartilage.
Methods: Femoral heads were obtained from 10 patients who had
femoral neck fractures without OA, and also from 10 OA patients
undergoing total hip arthroplasty. For methylation speciﬁc polymerase
chain reaction (MS-PCR), CpG rich regions within upstream sequences 5
kb from the transcription start site were analyzed. Putative CpG-rich
islands and respective primers for MS-PCR were searched from the CpGIsland Searcher and the MethPrimer program, respectively. In bisulﬁte
sequencing, primers were designed based on MethPrimer program and
sequences were analyzed using 2BLAST.
Results: Methylation of SOX-9 promoter region increased in OA carti-
lage compared to normal cartilage. FromMS-PCR, methylation status of
SOX-9 for R3 (from -3653 to -3496, p¼0.0186) and R4-1 (from -3111 to
-2983, p¼0.0014) signiﬁcantly increased in OA cartilage compared
to normal cartilage. When we analyzed regions (BSQ1-5) from -4548 to
-2846 in the promoter of SOX-9 by bisulﬁte sequencing, methylated
CpG sites signiﬁcantly increased in all the examined regions: total
methylated CpG sites increased about eight-fold in OA cartilage
(14.04%) than in normal cartilage (1.66%).
Conclusions: Our study suggests that the increased methylation status
in the SOX-9 promoter region may have a close relation to the
progression of OA.
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MICROARRAY STUDIES OF SYNOVIAL SPECIMEN OF EARLY HUMAN
(CHECK) AND EXPERIMENTAL OA IDENTIFY PATHWAYS AND
PROCESSES ASSOCIATED WITH CARTILAGE DAMAGE
A.B. Blom 1, P.L. van Lent 1, M. van den Bosch 1, H. Cats 2, P.M. van der
Kraan 1, W.B. van den Berg 1. 1Radboud Univ. Med. Ctr. Nijmegen,
Nijmegen, Netherlands; 2 Sint Maartenskliniek, Nijmegen, Netherlands
Purpose: Over 50% of osteoarthritis (OA) patients show synovial
inﬂammation, even relatively early during the disease. However,
the mechanisms through which this synovial activation contributes
to the irreversible joint pathology that characterizes OA, are not
known. In the present study we used microarray analysis of
synovial tissue of early OA patients and of experimental OA, to
identify common pathways that determine cartilage damage in this
disease.
Methods: From a subpopulation of patients that entered the CHECK
Cohort study (Cohort Hip and Cohort Knee), synovial biopsies were
collected. CHECK is a prospective 10-year follow-up study that was
initiated by the Dutch Arthritis Association on participants with
early osteoarthritis-related complaints of hip and/or knee. Radio-
graphs are taken in a standardized manner and scored (Kell-
gren&Lawrence KL) at inclusion (n¼18). In addition, biopsies of 7
control synovia were collected. A longitudinal expression analysis
was performed on murine synovial tissue at day 7, day 21 and day
42 after induction of collagenase induced OA (CIOA). CIOA was
induced by intra-articular injection of collagenase, which causes
joint instability, and contra lateral knee joints served as controls.
Initial analysis of microarray data was performed using Partek
software and functional annotation clustering (FAC) and pathway
analysis was done using DAVID.
Results: Gene expression proﬁles of control synovia were compared
to CHECK synovia. Analysis using DAVID indicated enrichment of
several biological processes and signaling pathways, including
regulation of macrophage differentiation, innate immune responses,
cell migration, TGFb-, BMP- and wnt-signaling. This indicates clear
activation of the synovium in the CHECK patients compared to
controls. Next we compared synovial tissue of CHECK-patients with
radiological damage (KL1) with CHECK-patients without joint
damage (KL¼0). Among the top 30 genes that were strongest asso-
ciated with cartilage damage were MMP-1 (18-fold), MMP-3 (10-
fold), S100A8 (6-fold) and cartilage glycoprotein-39 (6-fold), all of
which have been associated with cartilage damage. Immunohisto-
chemical staining revealed that expression of MMP-1 and MMP-3
was highest in the synovial lining layer. FAC analysis showed that,
among others, response to wounding, chemotaxis, innate immune
response and metalloproteases were strongly and signiﬁcantly
enriched and thus associated with joint damage. Pathway analysis
demonstrated that in the synovium of patients with joint damage
the complement-activation pathway, TGFb- and BMP-signaling and
TLR-activation were signiﬁcantly upregulated. These results were
further underlined by analysis of synovium from experimental OA.
Among the genes that were strongly upregulated on all 3 time points
after induction were MMP-3 (6-fold), MMP-13 (16-fold), MMP-14 (6-
fold) and COMP (13-fold). Again, wound healing, innate immune
response and metalloproteases were signiﬁcantly enriched, as were
the complement pathway, the TLR-, TGFb, BMP and wnt-signaling
pathways. In a recent publication, complement was demonstrated to
be essential in experimental OA. We therefore determined whether
Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S42the synovium expressed complement activating proteins, and found
a strong upregulation of COMP, lumican, osteomodulin, biglycan,
decorin and ﬁbromodulin. In addition, biglycan expression was
strongly enhanced (2.5-fold) in human CHECK-samples from patients
with joint damage.
Conclusions: All in all, these data suggest an active role for the
synovium in OA pathology, and identiﬁes pathways that are likely
to be involved. One of the strongest associations was of the
complement-pathway with cartilage damage. In addition, TGFb-,
BMP- and wnt-signaling in the synovium, may contribute to further
joint damage. The enhanced expression of cartilage damaging
MMP-1, MMP-3 and MMP-13 again suggests an active role of the
synovium in OA pathology. Future studies will focus on association
of gene expression patterns with progression of damage of CHECK-
patients.
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IDENTIFICATION AND CHARACTERISATION OF MICRORNAS
INVOLVED IN CHONDROCYTE DIFFERENTIATION AND
OSTEOARTHRITIS
T.E. Swingler 1, N. Crowe 1, K. Sorefan 1, L. Le 1, G. Wheeler 1,
V. Carmont 1, H.R. Elliott 2, M.J. Barter 2, M. Abu-Elmagd 1,
S.T. Donell 1, R.P. Boot-Handford 3, M.K. Hajihosseini 1,
A. Münsterberg 1, T. Dalmay 1, D.A. Young 2, I.M. Clark 1. 1Univ. of East
Anglia, Norwich, United Kingdom; 2Univ. of Newcastle, Norwich, United
Kingdom; 3Univ. of Manchester, Norwich, United Kingdom
Purpose: The majority of bones develop through the process of endo-
chondral ossiﬁcation where a cartilaginous template is calciﬁed and
remodelled into bone. During this process chondrocytes undergo
proliferation and differentiation. Many of the signalling pathways and
transcription factors which control this developmental programme
have been established. MicroRNAs are 20-24 nucleotide non-coding
RNA molecules that post-transcriptionally regulate gene expression.
There is strong evidence that they can inﬂuence both chondrogenesis
and the initiation and progression of osteoarthritis (OA), however the
exact mechanisms are still undetermined. In this study we aimed to
proﬁle expression of miRNAs in a cell model of chondrocyte differen-
tiation and use this to prioritise miRNAs for functional analyses in OA.
Using deep sequencing we also aimed to identify novel miRNAs
expressed in human articular cartilage.
Methods: The ATDC5 murine embryonic carcinoma cell line was
induced to differentiate through chondrogenesis in vitro. An Exiqon
miRNA microarray was used to proﬁle the expression of all known
murine miRNAs across this cell model. Expression of regulated miR-
NAs was veriﬁed in the mouse and chick embryo by in situ hybrid-
isation. The. 3’ UTRs of potential target genes were subcloned
downstream of a luciferase gene for experimental. Novel miRNAs
expressed in human articular cartilage were identiﬁed using deep
sequencing with Illumina's GAIIX system and validated in primary
chondrocyte culture in vitro.
Results: The expression of a number of microRNAs was regulated across
chondrogenesis. This includes 39 microRNAs co-expressed with
microRNA-140, known to be involved in cartilage homeostasis and
osteoarthritis. Of these, microRNA-455 resides within an intron of
COL27A1 which encodes a cartilage collagen. Comparing human oste-
oarthritic cartilage with femoral neck fracture controls, both microRNA-
140-5p and microRNA-455-3p show increased expression in osteoar-
thritic cartilage. In situ hybridisation shows microRNA-455-3p expres-
sion in the developing limbs of chicks and mice and in human
osteoarthritic cartilage. The expression of microRNA-455-3p is regu-
lated by TGFb ligands and the microRNA regulates TGFb signalling.
ACVR2B, SMAD2 and CHRDL1 are direct targets of miR-455-3p and may
mediate its functional impact on TGFb signalling. Deep sequencing of
the small RNA pool from chondrocytes extracted from primary human
osteoarthritic cartilage identiﬁed 16 potential novel miRNAs. These
have been validated in cultured chondrocytes using qRT-PCR, Northern
blot and Dicer knockdown.
Conclusions:MicroRNA-455 is expressed during chondrogenesis and in
adult articular cartilage where it can regulate TGFb signalling, sup-
pressing the Smad2/3 pathway. Diminished signalling through this
pathway in ageing and osteoarthritic chondrocytes is known to
contribute to cartilage destruction. We propose that the increase in
microRNA-455 in osteoarthritis exacerbates this process andcontributes to disease pathology. Novel miRNAs expressed in cartilage
may regulate cartilage homeostasis and contribute to disease.
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THE ANALYSIS OF THE GENOME-WIDE DNA METHYLATION PROFILE
OF HUMAN ARTICULAR CHONDROCYTES REVEALS DIFFERENT
FORMS OF OA.
J. Fernández-Tajes 1, M. Fernández-Moreno 1, M. Tamayo-Novás 2,
A. Mosquera-Rey 2, N. Oreiro-Villar 1, C. Fernández-López 1,
J.L. Fernández-García 2, I. Rego-Pérez 1, F.J. Blanco 1. 1 INIBIC-CHUAC.
Rheumatology Div.. Genomic Group., A Coruña, Spain; 2 INIBIC-CHUAC.
Genetic Dept.., A Coruña, Spain
Purpose: To identify and analyze the genome-wide DNA methylation
proﬁles of human articular chondrocytes from a population-based case-
control study of OA.
Methods: DNAmethylation proﬁling was performed using the Inﬁnium
HumanMethylation27 beadchip (Illumina Inc.), which allows interro-
gation of 27,578 highly informative CpG loci. Previously, cartilage iso-
lated DNA from 23 OA patients and 19 healthy controls was bisulﬁte-
modiﬁed, using the EZ DNA methylation kit (Zymo Research) and
hybridized according to the manufacturer’s instructions. DNA methyl-
ation b-values were normalized using GenomeStudio v3.0 (Illumina
Inc.). Appropriate bioinformatics analyses were carried out using both R
bioconductor software packages and Babelomics suite v 4.2
(babelomics.bioinfo.cipf.es).
Results: A ﬁrst approach based on an unsupervised clustering method
for the most variable CpG loci (n¼508) showed three distinct groups
of samples, called cluster 1 (5 OA patiens), cluster 2 (6 OA patients)
and cluster 3 (12 OA patients and 17 healthy controls). Speciﬁcally,
cluster 2 formed a particularly tight cluster with a characteristic DNA
methylation proﬁle (Figure 1). The analyses of the biological relevance
of the differentially methylated genes in cluster 2 compared with non-
cluster 2 by means of a gene set enrichment approach, showed that
the biological processes signiﬁcantly altered were those related to the
superoxide metabolic process, morphogenesis/angiogenesis and
regulation of cell proliferation, all of them hypermethylated in cluster
2; on the contrary, those mechanisms related to both IL-8 biosynthetic
process and apoptosis appeared signiﬁcantly hypomethylated in
cluster 2.
Conclusions: The genome-wide methylation analysis shows a clearly
distinct epigenetic proﬁle for OA. The DNA methylation proﬁle could
be one of the reasons of the existence of different forms of OA and
could also be related to both the prevalence and progression of this
disease.
